Structure |
Chemical Name |
CAS |
MF |
![Unii-o0p4I5851i](/CAS/20180808/GIF/139563-29-4.gif) |
Unii-o0p4I5851i |
139563-29-4 |
C28H37ClN4O2S |
![デヒドロモナコリンK](/CAS/GIF/109273-98-5.gif) |
デヒドロモナコリンK |
109273-98-5 |
C24H34O4 |
![(2b,3a,16b,17b)-2,16-Bispiperidino-3,17-diacetoxy-5-androstane](/CAS/GIF/13529-31-2.gif) |
(2b,3a,16b,17b)-2,16-Bispiperidino-3,17-diacetoxy-5-androstane |
13529-31-2 |
C33H54N2O4 |
![Palbociclib Impurity 59](/CAS/20200611/GIF/1430196-98-7.gif) |
Palbociclib Impurity 59 |
1430196-98-7 |
C14H20N4O4 |
![Landiolol impurity Z](/) |
Landiolol impurity Z |
|
|
![Vitamin K1 Impurity 1](/CAS/20200515/GIF/19274-66-9.gif) |
Vitamin K1 Impurity 1 |
19274-66-9 |
C31H46O2 |
![Teneligliptin Impurity 13](/) |
Teneligliptin Impurity 13 |
|
|
![Ceftazidime EP Impurity D](/CAS/20210111/GIF/73547-69-0.gif) |
Ceftazidime EP Impurity D |
73547-69-0 |
C45H44N6O7S2 |
![Nicergoline EP Impurity G](/CAS/20210111/GIF/57935-65-6.gif) |
Nicergoline EP Impurity G |
57935-65-6 |
C23H24BrN3O2 |
![Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]-](/CAS/20200401/GIF/2356153-95-0.gif) |
Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]- |
2356153-95-0 |
C17H14F3N3O3S |
![2-Pyrrolidinecarbonitrile, 1-(2-aminoacetyl)-, hydrochloride (1:1), (2S)-](/CAS/20211123/GIF/913980-23-1.gif) |
2-Pyrrolidinecarbonitrile, 1-(2-aminoacetyl)-, hydrochloride (1:1), (2S)- |
913980-23-1 |
C7H12ClN3O |
![Lamivudine Impurity 7](/CAS/20211123/GIF/147126-63-4.gif) |
Lamivudine Impurity 7 |
147126-63-4 |
C14H24O4S |
![EsCitalopram EP Impurity I](/CAS/20210305/GIF/1370643-22-3.gif) |
EsCitalopram EP Impurity I |
1370643-22-3 |
C20H21FN2O |
![(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine](/CAS/20200401/GIF/127017-42-9.gif) |
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine |
127017-42-9 |
C21H25NO4 |
![Methylprednisolone Impurity 21](/CAS/20200401/GIF/150899-33-5.gif) |
Methylprednisolone Impurity 21 |
150899-33-5 |
C22H28O4 |
![Epinephrine Impurity 7](/CAS/20200401/GIF/62322-82-1.gif) |
Epinephrine Impurity 7 |
62322-82-1 |
C9H11NO3 |
![(trans)-4-((2-amino-4,6-dibromobenzyl)amino)cyclohexanol](/CAS/20200401/GIF/CB95519892.gif) |
(trans)-4-((2-amino-4,6-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
![Fesoterodine Impurity 14](/) |
Fesoterodine Impurity 14 |
|
|
![Dexamethasone EP impurities E](/) |
Dexamethasone EP impurities E |
|
|
![(R)-N-((S)-2-aminobutanoyl)-3-(bromomethyl)hexanamide](/CAS/20200401/GIF/CB95559995.gif) |
(R)-N-((S)-2-aminobutanoyl)-3-(bromomethyl)hexanamide |
|
C11H21BrN2O2 |
![Empagliflozin Impurity 57(R,R)](/) |
Empagliflozin Impurity 57(R,R) |
|
|
![Aripiprazole peroxide degradation Impurity (MW:303Da)](/) |
Aripiprazole peroxide degradation Impurity (MW:303Da) |
|
|
![Pramipexole Impurity Reference](/) |
Pramipexole Impurity Reference |
|
|
![2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid Gd3+](/) |
2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid Gd3+ |
|
|
![3-[4-(acetyloxymethyl)phenyl]-2-propenoic acid methyl ester](/CAS/20200515/GIF/100688-45-7.gif) |
3-[4-(acetyloxymethyl)phenyl]-2-propenoic acid methyl ester |
100688-45-7 |
C13H14O4 |
![Acetaminophen Impurity 14](/CAS/20210111/GIF/1991204-56-8.gif) |
Acetaminophen Impurity 14 |
1991204-56-8 |
C16H18N2O2 |
![Ketoconazole Impurity 7](/CAS/20200515/GIF/172032-21-2.gif) |
Ketoconazole Impurity 7 |
172032-21-2 |
C11H12Cl2O3 |
![Rosuvastatin Impurity 59](/) |
Rosuvastatin Impurity 59 |
|
|
![Losartan Impurity 12](/CAS/20211123/GIF/727718-93-6.gif) |
Losartan Impurity 12 |
727718-93-6 |
C22H22ClN9 |
![benzyl (2S)-2-amino-3-(4-methanesulfonylphenyl)propanoate hydrochloride](/CAS/20210111/GIF/1865726-28-8.gif) |
benzyl (2S)-2-amino-3-(4-methanesulfonylphenyl)propanoate hydrochloride |
1865726-28-8 |
C17H19NO4S |
![Glycopyrrolate Impurity 12](/CAS/20211123/GIF/857353-41-4.gif) |
Glycopyrrolate Impurity 12 |
857353-41-4 |
C13H14O3 |
![(4S,4aR,5R,12aS)-4-(dimethylamino)-3,5,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide](/CAS/20210111/GIF/4660-26-8.gif) |
(4S,4aR,5R,12aS)-4-(dimethylamino)-3,5,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide |
4660-26-8 |
C22H22N2O8 |
![Regorafenib Impurity 38](/) |
Regorafenib Impurity 38 |
|
|
![Cefazolin Impurity 28](/) |
Cefazolin Impurity 28 |
|
|
![Vonoprazan Impurity 57](/) |
Vonoprazan Impurity 57 |
|
|
![Tafluprost Impurity 9](/CAS/20210111/GIF/2099033-66-4.gif) |
Tafluprost Impurity 9 |
2099033-66-4 |
C27H41NO8 |
![2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-5-hydroxy-7,8-dimethoxy-](/CAS/20200515/GIF/2253977-80-7.gif) |
2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-5-hydroxy-7,8-dimethoxy- |
2253977-80-7 |
C27H36N2O6 |
![Benzeneacetic acid, 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, methyl ester](/CAS/20211123/GIF/1187954-56-8.gif) |
Benzeneacetic acid, 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, methyl ester |
1187954-56-8 |
C33H41NO4 |
![N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-Adenosine 5''-(hydrogen P-1H-imidazol-1-ylphosphonate)](/CAS/20210111/GIF/1054332-15-8.gif) |
N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-Adenosine 5''-(hydrogen P-1H-imidazol-1-ylphosphonate) |
1054332-15-8 |
C19H25F3N7O6PS2 |
![N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide](/CAS/20200611/GIF/2211059-00-4.gif) |
N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide |
2211059-00-4 |
C19H21BrN6O4S |
![Isomer 1 of Tazobactam Impurity 3](/) |
Isomer 1 of Tazobactam Impurity 3 |
|
|
![Ceftiofur USP Impurity I](/) |
Ceftiofur USP Impurity I |
|
|
![Cephalexin Degradation Impurity A](/) |
Cephalexin Degradation Impurity A |
|
|
![Pregabalin-8687(mixture of 4 isomers)](/) |
Pregabalin-8687(mixture of 4 isomers) |
|
|
![7-(2-chloropropanoyl)-5H-chromeno[2,3-b]pyridin-5-one](/) |
7-(2-chloropropanoyl)-5H-chromeno[2,3-b]pyridin-5-one |
|
|
![1-(5H-chromeno[2,3-b]pyridin-7-yl)-2-methoxypropan-1-one](/) |
1-(5H-chromeno[2,3-b]pyridin-7-yl)-2-methoxypropan-1-one |
|
|
![(E)-4-chloro-6-(3-(2,4-difluorophenyl)-4-(1H-1,2,4-triazol-1-yl)but-3-en-2-yl)-5-fluoropyrimidine](/) |
(E)-4-chloro-6-(3-(2,4-difluorophenyl)-4-(1H-1,2,4-triazol-1-yl)but-3-en-2-yl)-5-fluoropyrimidine |
|
|
![Dolutegravir Impurity C](/CAS/20210111/GIF/1802141-49-6.gif) |
Dolutegravir Impurity C |
1802141-49-6 |
C22H23F2N3O5 |
![Dapoxetine Impurity 68](/CAS/20210111/GIF/119357-48-1.gif) |
Dapoxetine Impurity 68 |
119357-48-1 |
C19H18O |
![Tobramycin Impurity](/CAS/20211123/GIF/74501-86-3.gif) |
Tobramycin Impurity |
74501-86-3 |
C18H35N5O8 |
![Peramivir Impurity 24](/) |
Peramivir Impurity 24 |
|
|
![2-CHLORO-6-AMINO-9-(2',3',5'-TRI-O-ACETYL--D-RIBOFURANOSYL)PURINE](/CAS/GIF/79999-39-6.gif) |
2-CHLORO-6-AMINO-9-(2',3',5'-TRI-O-ACETYL--D-RIBOFURANOSYL)PURINE |
79999-39-6 |
C16H18ClN5O7 |
![Sugammadex sodium Impurity 46](/) |
Sugammadex sodium Impurity 46 |
|
|
![Tenofovir Impurity 103](/) |
Tenofovir Impurity 103 |
|
|
![Tafluprost Impurity 17](/) |
Tafluprost Impurity 17 |
|
|
![Labetalol EP impurity E](/) |
Labetalol EP impurity E |
|
|
![1-Propanol, 3-(2-methoxy-5-nitrophenoxy)-](/CAS/20180703/GIF/1156068-41-5.gif) |
1-Propanol, 3-(2-methoxy-5-nitrophenoxy)- |
1156068-41-5 |
C10H13NO5 |
![1616710-52-1](/CAS/20211123/GIF/1616710-52-1.gif) |
1616710-52-1 |
1616710-52-1 |
C27H34N2O6 |
![6-ヒドロキシオンダンセトロン](/CAS/GIF/110708-17-3.gif) |
6-ヒドロキシオンダンセトロン |
110708-17-3 |
C18H19N3O2 |
![8-クロロ-5,6-ジヒドロ-11H-ベンゾ[5,6]シクロヘプタ[1,2-b]ピリジン-11-オン](/CAS/GIF/31251-41-9.gif) |
8-クロロ-5,6-ジヒドロ-11H-ベンゾ[5,6]シクロヘプタ[1,2-b]ピリジン-11-オン |
31251-41-9 |
C14H10ClNO |
![(R)-Ornidazole](/CAS/20210305/GIF/166734-80-1.gif) |
(R)-Ornidazole |
166734-80-1 |
C7H10ClN3O3 |
![Bendamustine Related Impurity 22](/) |
Bendamustine Related Impurity 22 |
|
|
![Cabozantinib impurity 44](/) |
Cabozantinib impurity 44 |
|
|
![Cabozantinib impurity 40](/) |
Cabozantinib impurity 40 |
|
|
![Cabozantinib impurity 74](/) |
Cabozantinib impurity 74 |
|
|
![Doxofylline Impurity 25](/) |
Doxofylline Impurity 25 |
|
|
![2-メトキシ-4-[(E)-1-プロペニル]フェノール](/CAS/GIF/5932-68-3.gif) |
2-メトキシ-4-[(E)-1-プロペニル]フェノール |
5932-68-3 |
C10H12O2 |
![3-アミノ-5-[(メチルチオ)メチル]オキサゾリジン-2-オン](/CAS/GIF/25517-72-0.gif) |
3-アミノ-5-[(メチルチオ)メチル]オキサゾリジン-2-オン |
25517-72-0 |
C5H10N2O2S |
![Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI)](/CAS/20210305/GIF/107021-20-5.gif) |
Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI) |
107021-20-5 |
C9H14N5O4P |
![Sitagliptin EP Impurity 7](/) |
Sitagliptin EP Impurity 7 |
|
|
![Sitagliptin EP Impurity H](/) |
Sitagliptin EP Impurity H |
|
|
![7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]-](/CAS/20210305/GIF/2636673-48-6.gif) |
7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
2636673-48-6 |
C18H26ClN3O4 |
![Beprostatin impurity 4](/) |
Beprostatin impurity 4 |
|
|
![N-(メトキシカルボニル)-p-トルエンスルホンアミド](/CAS/GIF/14437-03-7.gif) |
N-(メトキシカルボニル)-p-トルエンスルホンアミド |
14437-03-7 |
C9H11NO4S |
![(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium](/CAS/20211123/GIF/786598-71-8.gif) |
(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium |
786598-71-8 |
C21H28NO3+ |
![(S)-レパグリニドエチルエステル (REPAGLINIDE IMPURITY)](/CAS/GIF/147770-06-7.gif) |
(S)-レパグリニドエチルエステル (REPAGLINIDE IMPURITY) |
147770-06-7 |
C29H40N2O4 |
![4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride](/CAS/GIF/152402-97-6.gif) |
4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride |
152402-97-6 |
C7H8Cl3N |
![4-(3-CYANO-2-METHYLPROPIONYL)ACETAMILIDE](/CAS/GIF/42075-21-8.gif) |
4-(3-CYANO-2-METHYLPROPIONYL)ACETAMILIDE |
42075-21-8 |
|
![Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime]](/CAS/GIF/119699-81-9.gif) |
Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] |
119699-81-9 |
C48H94N2O14Si2 |
![(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione](/) |
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
![Isavuconazole Impurity 37](/) |
Isavuconazole Impurity 37 |
|
|
![N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide](/CAS/20210305/GIF/1375004-39-9.gif) |
N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
1375004-39-9 |
C29H39BN4O4 |
![(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile](/) |
(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile |
|
|
![Mannitol EP impurity B](/) |
Mannitol EP impurity B |
|
|
![Mannitol EP impurity A](/) |
Mannitol EP impurity A |
|
|
![Peramivir Amino Carboxylic Isomerism Impurity](/) |
Peramivir Amino Carboxylic Isomerism Impurity |
|
|
![Peramivir Chlorinated Impurity](/) |
Peramivir Chlorinated Impurity |
|
|
![Brivaracetam Impurity 999](/) |
Brivaracetam Impurity 999 |
|
|
![Dasatinib impurity 48](/) |
Dasatinib impurity 48 |
|
|
![Pemetrexed Impurity 120](/) |
Pemetrexed Impurity 120 |
|
|
![Ticagrelor Impurity 101](/) |
Ticagrelor Impurity 101 |
|
|
![4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane](/) |
4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |
|
|
![1-(3-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride](/) |
1-(3-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride |
2137793-92-9 |
|
![(R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97%](/CAS/GIF/103765-03-3.gif) |
(R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97% |
103765-03-3 |
C4H11ClN2O |
![Flomoxef Impurity 20 Sodium Salt](/CAS/20210305/GIF/2095697-77-9.gif) |
Flomoxef Impurity 20 Sodium Salt |
2095697-77-9 |
C15H18F2N6O7S2 |
![((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate](/CAS/20211123/GIF/2591381-21-2.gif) |
((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate |
2591381-21-2 |
C9H16O6 |
![3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester](/CAS/20210305/GIF/2591260-07-8.gif) |
3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester |
2591260-07-8 |
C25H23BrF2N2O6S |
![Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel-](/CAS/20210305/GIF/190582-37-7.gif) |
Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel- |
190582-37-7 |
C23H32N4O3S |
![Ivabradine Impurity II](/) |
Ivabradine Impurity II |
|
|
![(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate](/CAS/20211123/GIF/792155-94-3.gif) |
(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
792155-94-3 |
C18H19NO4S2 |